Getting to Yes, Michigan! (G2YMI)
This study entitled Community-Centered Interventions for Improved Vaccine Uptake for COVID-19 (CIVIC): Getting to Yes, Michigan!, is designed to increase vaccine uptake among populations that experience COVID-19 related disparities. The investigators will focus on the four counties within Michigan where a disproportionate burden of COVID-19 is within African Americans and Latinx communities, i.e., Wayne, Genesee, Kent and Washtenaw Counties. Using a community-based participatory research (CBPR) approach, CIVIC will leverage: its long term relationships with the communities involved, an established CBPR Steering Committee developed and the knowledge gained as a Community Engagement Alliance (CEAL) grant recipient, the resources and networks of the University of Michigan CTSA (MICHR), and the expertise of our academic partners to identify and understand factors that contribute to COVID-19 vaccine hesitancy in African Americans and Latinx communities in Michigan. The investigators will develop and test interventions based on community-centered approaches to achieve a primary goal of increased vaccine uptake.
The investigators will achieve this goal with the following aims:
1. Increase understanding of the barriers and drivers of vaccine uptake and hesitancy;
2. Increase vaccine uptake and decrease vaccine hesitancy through the implementation and evaluation of a multi-component intervention; and maintain, enhance, and evaluate the effectiveness of the CIVIC partnership to equitably engage all partners.
Conditions:
🦠 COVID-19 Vaccines
🦠 COVID-19 Pandemic
🗓️ Study Start (Actual)
5 July 2022
🗓️ Primary Completion (Estimated)
5 September 2024
✅ Study Completion (Estimated)
30 September 2024
👥 Enrollment (Estimated)
700
🔬 Study Type
INTERVENTIONAL
📊 Phase
NA
Locations:
📍
Ann Arbor, Michigan, United States
Description
Inclusion Criteria:
- * unvaccinated or unboosted adults 18 years and older who are interested in participating in the study OR vaccinated and boosted adults 18 years and older who are interested in becoming a Champion.
- * Must be able to read and write in English or Spanish
- * Must be able to receive SMS/MMS/text messages
Exclusion Criteria:
- * Persons under the age of 18
- * unable to read or write English or Spanish
- * unable or unwilling to receive SMS/MMS
- * unwilling to consent
- * for vaccine champions-unwillingness to complete communication trainings in English
- No specific racial, ethnic, nor sex/gender group is excluded.
Ages Eligible for Study:
18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Yes
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported
results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before
being posted on the public website.
Study Registration Dates
- First Submitted
14 October 2021
- First Submitted that Met QC Criteria
14 October 2021
- First Posted
27 October 2021
Study Record Updates
- Last Update Submitted that Met QC Criteria
16 May 2024
- Last Update Posted
21 May 2024
- Last Verified
May 2024